Safety, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Dose of VRS-859 in Patients With Type 2 Diabetes

被引:0
|
作者
Cleland, Jeffrey L.
Aronson, Ronnie
Humphriss, Eric
Shore, Camille
Zhou, Rong
Kipnes, Mark S.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1105-P
引用
收藏
页码:A285 / A285
页数:1
相关论文
共 50 条
  • [31] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Silke Retlich
    Vincent Duval
    Ulrike Graefe-Mody
    Christian Friedrich
    Sanjay Patel
    Ulrich Jaehde
    Alexander Staab
    Clinical Pharmacokinetics, 2015, 54 : 737 - 750
  • [32] Single dose pharmacokinetics of glimepiride (GLIM) in pediatric patients with type 2 diabetes mellitus
    Connor, JD
    Gottschalk, M
    Prescilla, R
    Vlajnic, A
    Harris, A
    Kovacs, SJ
    DIABETES, 2005, 54 : A141 - A141
  • [33] Single-dose safety, pharmacokinetics (PK) and pharmacodynamics (PD) of fexinidazole
    Tarral, A.
    Blesson, S.
    Valverde, O.
    Hovsepian, L.
    Even, E.
    Strub-Wourgaft, N.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 176 - 176
  • [34] Liraglutide trial in paediatric subjects with type 2 diabetes: safety, tolerability and pharmacokinetics/pharmacodynamics
    Battelino, T.
    Klein, D.
    Chatterjee, D. J.
    Hale, P.
    Chang, C. T.
    Arslanian, S.
    DIABETOLOGIA, 2012, 55 : S7 - S7
  • [35] Influence of Renal Function on Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Romosozumab
    Hsu, Cheng-Pang
    Maddox, Judy
    Block, Geoffrey
    Bartley, Yessenia
    Yu, Zhigang
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (09): : 1132 - 1141
  • [36] Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
    Dias, Clapton
    Moore, Kenneth Todd
    Murphy, Joe
    Ariyawansa, Jay
    Smith, William
    Mills, Roger M.
    Weir, Matthew R.
    AMERICAN JOURNAL OF NEPHROLOGY, 2016, 43 (04) : 229 - 236
  • [37] Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single-Dose Administration in Healthy Japanese and White Adults
    Glassman, Fiona
    Lawo, John-Philip
    Bica, Mihai Alexandru
    Roberts, Anthony
    Pawaskar, Dipti
    Akama, Hideto
    Jain, Meena
    Goodson, Summer
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [38] Ascending Single Intravenous And Subcutaneous Dose Studies Of Benralizumab In Japanese Healthy Male Volunteers: Safety, Tolerability, Pharmacokinetics And Pharmacodynamics
    Saito, H.
    Yuji, W.
    Kawai, H.
    Nakanishi, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [39] Pharmacokinetics, pharmacodynamics, safety and tolerability of 4 weeks' treatment with empagliflozin in Japanese patients with type 2 diabetes mellitus
    Kanada, Shigeto
    Koiwai, Kazuki
    Taniguchi, Atsushi
    Sarashina, Akiko
    Seman, Leo
    Woerle, Hans J.
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 613 - 617
  • [40] Single-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus
    Hussey, Elizabeth K.
    Clark, Richard V.
    Amin, Dipti M.
    Kipnes, Mark S.
    O'Connor-Semmes, Robin L.
    O'Driscoll, Eilis C.
    Leong, Jenny
    Murray, Sharon C.
    Dobbins, Robert L.
    Layko, Debbi
    Nunez, Derek J. R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (06): : 623 - 635